0000899243-22-026840.txt : 20220727
0000899243-22-026840.hdr.sgml : 20220727
20220727161744
ACCESSION NUMBER: 0000899243-22-026840
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220725
FILED AS OF DATE: 20220727
DATE AS OF CHANGE: 20220727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 221111228
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-25
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
Executive Chairman
Common Stock
2022-07-25
4
M
0
60342
91.05
A
134502
D
Common Stock
2022-07-25
4
S
0
13869
279.44
D
120633
D
Common Stock
2022-07-25
4
S
0
32983
280.37
D
87650
D
Common Stock
2022-07-25
4
S
0
34090
281.27
D
53560
D
Common Stock
2022-07-25
4
S
0
40666
282.43
D
12894
D
Common Stock
2022-07-25
4
S
0
10471
283.42
D
2423
D
Common Stock
440
I
401(k)
Stock Option (Right to Buy)
91.05
2022-07-25
4
M
0
60342
0.00
D
2026-02-01
Common Stock
60342
33524
D
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $279.44 (range $278.90 to $279.89).
Open market sales reported on this line occurred at a weighted average price of $280.37 (range $279.90 to $280.88).
Open market sales reported on this line occurred at a weighted average price of $281.27 (range $280.90 to $281.89).
Open market sales reported on this line occurred at a weighted average price of $282.43 (range $281.90 to $282.89).
Open market sales reported on this line occurred at a weighted average price of $283.42 (range $282.90 to $283.84).
Fully vested.
/s/ Joy Liu, Attorney-in-Fact
2022-07-27